Procedures treating peripheral artery disease to grow more than 70% by 2012

Jan. 21, 2008
January 21, 2008, Waltham, MA--According to a new research report from Millennium Research Group, minimally invasive procedures treating peripheral artery disease (PAD) will grow more than 70% by 2012, driven largely by the availability of successful treatment options including laser atherectomy and thrombectomy.

January 21, 2008, Waltham, MA--According to a new research report from Millennium Research Group, "US Markets for Plaque and Thrombus Management Devices 2008," minimally invasive procedures treating peripheral artery disease (PAD) will grow more than 70% by 2012, driven largely by the availability of successful treatment options including laser atherectomy and thrombectomy.

Today, only a small subset of patients actually receives an interventional treatment. Often times, PAD patients are treated with bypass surgery or worse, are forced to have limbs amputated because PAD is not caught in time. Less invasive procedures, such as atherectomy and thrombectomy, which remove plaque and thrombus matter that has formed along the vessel wall, are available if the disease is diagnosed before the critical end stage of its lifecycle.

Physician awareness of minimally invasive plaque and thrombus management procedures is expanding primarily due to research and clinical trials on a number of innovative devices. As a result, more physicians will adopt these new technologies, thus driving procedure growth and improving patient care.

"Today, physicians have more options for treating patients with PAD," says Bina Mistry, analyst at Millennium Research Group. "Specifically, we are noticing a large increase in the number of individuals receiving laser atherectomy and mechanical thrombectomy--two types of plaque and thrombus removal procedures--both in the US and in Europe."

The "Plaque and Thrombus Management Devices 2008" series includes coverage in the US and Europe for atherectomy, thrombectomy, chronic total occlusion crossing devices, and embolic protection devices. Coverage of industry competitors includes FoxHollow Technologies (ev3), Boston Scientific, Possis Medical, Spectranetics, and many others.

Sponsored Recommendations

Manufacturing thin films with tailor-made electronic properties

Dec. 5, 2023
Unlock the future of optoelectronics as researchers at Leibniz IPHT in Jena, Germany unveil an innovative technique for precision deposition of thin organic semiconductor films...

Quantitative Microscopy with Deep Learning

Dec. 5, 2023
Explore the untapped potential of deep learning in video microscopy with our cutting-edge software, DeepTrack 2.2. Overcoming the steep learning curve, this innovative application...

Stimulated Brillouin scattering enhances CMOS chip for microwave signal processing

Dec. 5, 2023
University of Sydney Nano Institute researchers are pioneering photonic silicon chips and helping spur growth in Australia’s semiconductor industry.

Current Trends in Laser Absorption Spectroscopy: More than Just Beer's Law

Dec. 5, 2023
Dive into the cutting-edge world of absorption spectroscopy in our upcoming webinar, exploring groundbreaking techniques such as cavity ringdown spectroscopy, photoacoustic spectroscopy...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!